AKERO THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 202[●] Subordinated Debt SecuritiesIndenture • July 1st, 2020 • Akero Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 1st, 2020 Company Industry JurisdictionINDENTURE, dated as of [●], 202[●] , among AKERO THERAPEUTICS, INC.., a Delaware corporation (the “Company”), and [TRUSTEE] as trustee (the “Trustee”):
GENZYME CORPORATION, as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of June 17, 2010Indenture • June 17th, 2010 • Genzyme Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledJune 17th, 2010 Company Industry JurisdictionINDENTURE, dated as of June 17, 2010, between Genzyme Corporation, a Massachusetts corporation (herein called the “Company”), having its principal executive offices at 500 Kendall Street, Cambridge, Massachusetts 02142, and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (herein called the “Trustee”).
US AIRWAYS GROUP, INC., ISSUER AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., TRUSTEE GUARANTEED TO THE EXTENT SET FORTH THEREIN BY THE GUARANTORS NAMED HEREIN INDENTURE DATED AS OF MAY 13, 2009 DEBT SECURITIESIndenture • May 14th, 2009 • Us Airways Inc • Air transportation, scheduled • New York
Contract Type FiledMay 14th, 2009 Company Industry JurisdictionINDENTURE, dated as of May 13, 2009, among US AIRWAYS GROUP, INC., a Delaware corporation (the “Company”), the guarantors, if any, listed on Schedule 1 hereto (herein called the “Guarantors”) and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as trustee (the “Trustee”):